Pheton Holdings Operating Expenses 2023-2024 | PTHL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pheton Holdings operating expenses from 2023 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pheton Holdings operating expenses from 2023 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$146.6B
CVS Health (CVS)	$81.9B
Elevance Health (ELV)	$77B
Cencora (COR)	$57.2B
DiDi Global (DIDIY)	$24.2B
Natera (NTRA)	$21.9B
Labcorp Holdings (LH)	$20.9B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.7B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$12.2B
Revvity (RVTY)	$12B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9.3B
Avantor (AVTR)	$9.3B
Sonic Healthcare (SKHHY)	$8.9B
HealthEquity (HQY)	$8.2B
Charles River Laboratories (CRL)	$7.8B
Caris Life Sciences,�Inc (CAI)	$6.7B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.3B
Surgery Partners (SGRY)	$2.8B
Alignment Healthcare (ALHC)	$2.6B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Ardent Health (ARDT)	$2B